Patient identifier: no patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.Device evaluated by mfr: code b20: the device remains implanted in the patient.Therefore a device evaluation could not be performed.Device evaluated by mfr: review of the manufacturing records indicated the device met pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
On (b)(6) 2014, this patient underwent treatment for occlusion due to peripheral arterial disease (pad) in which a gore-tex® vascular graft was used as a bypass.The proximal anastomosis was at the common femoral artery, the distal anastomosis was at the tibial-peroneal trunk below knee.On (b)(6) 2014, an adverse event termed "thrombosis of the gore bypass" was identified.On (b)(6) 2014, a thrombectomy and an endarterectomy of the graft was performed.Graft patency was restored at the end of the procedure.The patient recovery was described as uneventful.On (b)(6) 2014, the patient was discharged to home.
|